StonvexLoading…
StonvexStonvexStonvexCore line items from CHRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.14M | $12.80M | $9.66M | $5.43M |
Operating Income | $-5.62M | $-13.33M | $-8.82M | $-7.42M |
Net Income | $-6.88M | $-11.70M | $-7.02M | $-2.71M |
EPS (Diluted) | $-2.04 | $-4.91 | $-3.35 | $-3.01 |
Total Assets | $19.67M | $20.11M | $21.66M | $23.17M |
Total Liabilities | $13.93M | $11.08M | $11.98M | $12.24M |
Cash & Equivalents | $3.99M | $1.17M | $2.72M | $5.24M |
Free Cash Flow OCF − CapEx | $-2.12M | $-11.99M | $-7.53M | $-5.46M |
Shares Outstanding | 3.56M | 3.56M | 2.62M | 2.60M |